Platinums for First-Line Treatment of Advanced NSCLC? Platinums for First-Line Treatment of Advanced NSCLC?
Recent clinical trials have put immunotherapy front and center for initial treatment decisions in advanced lung cancer.Journal of Clinical Oncology
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Hematology-Oncology Journal Article Source Type: news
More News: Cancer | Cancer & Oncology | Clinical Trials | Hematology | Immunotherapy | Intensive Care | Lung Cancer | Non-Small Cell Lung Cancer